Organization
Athos Therapeutics
1 clinical trial
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ATH-063 in Healthy SubjectsStatus: Completed, Estimated PCD: 2024-02-08